Cargando…
BARICITINIB IN HOSPITALIZED PATIENTS WITH COVID-19: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Autores principales: | SELVARAJ, VIJAIRAM, FINN, ARKADIY, LAL, AMOS, P CARINO, GERARDO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548841/ http://dx.doi.org/10.1016/j.chest.2022.08.765 |
Ejemplares similares
-
Baricitinib in hospitalised patients with COVID-19: A meta-analysis of randomised controlled trials
por: Selvaraj, Vijairam, et al.
Publicado: (2022) -
Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials
por: Selvaraj, Vijairam, et al.
Publicado: (2021) -
DISSEMINATED HERPES ZOSTER VIRUS INFECTION FOLLOWING BARICITINIB IN COVID-19
por: KAUR, GURSHARAN, et al.
Publicado: (2022) -
WHEN THE BEAT DROPS: A RETROSPECTIVE COHORT STUDY OF IN-HOSPITAL CARDIAC-ARREST CPR OUTCOMES OF PATIENTS WITH COVID-19
por: NOUREDDINE, BELAL, et al.
Publicado: (2021) -
REMDESIVIR PLUS DEXAMETHASONE VS TOCILIZUMAB OR BARICITINIB SUPPLEMENTATION INITIATED INSIDE 48 HOURS OF INDEX COVID-19 HOSPITALIZATION IN ICU PATIENTS
por: WILLIAMS, STEPHANIE N, et al.
Publicado: (2022)